Royce & Associates’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-349,000
| Closed | -$764K | – | 943 |
|
|
2022
Q2 | $764K | Hold |
349,000
| – | – | 0.01% | 790 |
|
|
2022
Q1 | $1.11M | Buy |
349,000
+98,000
| +39% | +$313K | 0.01% | 800 |
|
|
2021
Q4 | $1.05M | Buy |
251,000
+55,000
| +28% | +$231K | 0.01% | 799 |
|
|
2021
Q3 | $1.59M | Buy |
196,000
+59,000
| +43% | +$479K | 0.01% | 766 |
|
|
2021
Q2 | $1.03M | Hold |
137,000
| – | – | 0.01% | 847 |
|
|
2021
Q1 | $1.19M | Hold |
137,000
| – | – | 0.01% | 833 |
|
|
2020
Q4 | $1.09M | Hold |
137,000
| – | – | 0.01% | 804 |
|
|
2020
Q3 | $1.09M | Buy |
137,000
+20,000
| +17% | +$160K | 0.01% | 770 |
|
|
2020
Q2 | $1.16M | Buy |
117,000
+53,688
| +85% | +$531K | 0.01% | 755 |
|
|
2020
Q1 | $489K | Buy |
+63,312
| New | +$489K | 0.01% | 836 |
|